Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Lighthouse Lab Services SARS-CoV-2 PCR Test

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Lighthouse Lab Services' CovidNow SARS-CoV-2 Assay.

The RT-PCR-based test is designed to detect SARS-CoV-2 nucleic acid in upper respiratory specimens in both symptomatic and asymptomatic individuals. It may also be used with anterior nasal swab specimens self-collected at home by individuals 18 years of age and older using the CovidNow Collection Kit.

Use of the test is limited to laboratories authorized by Charlotte, North Carolina-based Lighthouse Lab Services and CLIA-certified to perform high-complexity tests.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.